Name: INSPIREMD INC (NSPR) Stock
Brand: INSPIREMD INC
Rating: 4 (3 reviews)

NSPR Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: InspireMD Inc.

Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting

11 days ago - By: InspireMD Inc.

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12 days ago - By: InspireMD Inc.

InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference

a month ago - By: Zacks Investment Research - Mentions: MASS

InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates

a month ago - By: InspireMD Inc.

InspireMD Reports Third Quarter 2025 Financial Results

a month ago - By: Benzinga - Mentions: KURA SEE HRMY FOLD ...

Earnings Scheduled For November 4, 2025

4 months ago - By: InspireMD Inc.

InspireMD Reports Second Quarter 2025 Financial Results

4 months ago - By: Benzinga - Mentions: AFG CXDO YUM PACK ...

Earnings Scheduled For August 5, 2025

7 months ago - By: InspireMD Inc.

InspireMD Reports First Quarter 2025 Financial Results

a month ago - By: Zacks Investment Research - Mentions: HOLX

Hologic (HOLX) Q4 Earnings and Revenues Beat Estimates

a month ago - By: InspireMD Inc.

InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer

2 months ago - By: InspireMD Inc.

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: InspireMD Inc.

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: InspireMD Inc.

InspireMD Announces the Appointment of Dan Dearen to its Board of Directors

3 months ago - By: InspireMD Inc.

InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference

4 months ago - By: RxSight, Inc. - Mentions: RXST AXNX KMTS

RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors

4 months ago - By: InspireMD Inc.

InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors

4 months ago - By: InspireMD Inc.

InspireMD Announces Combined Financings of $58 Million

4 months ago - By: InspireMD Inc.

InspireMD to Announce Second Quarter 2025 Financial Results

5 months ago - By: InspireMD Inc.

InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke

6 months ago - By: InspireMD Inc.

InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke

6 months ago - By: InspireMD Inc.

InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer

7 months ago - By: Stocktwits

InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic

7 months ago - By: Zacks Investment Research - Mentions: ELMD

InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates

7 months ago - By: Zacks Investment Research - Mentions: GMED

Globus Medical (GMED) Lags Q1 Earnings and Revenue Estimates

7 months ago - By: Zacks Investment Research - Mentions: IQV

IQVIA Holdings (IQV) Surpasses Q1 Earnings and Revenue Estimates

7 months ago - By: InspireMD Inc.

InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference

7 months ago - By: InspireMD Inc.

InspireMD to Announce First Quarter 2025 Financial Results

8 months ago - By: InspireMD Inc.

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

8 months ago - By: InspireMD Inc.

INSPIREMD INC (NSPR) Stock News

NSPR Latest News, Press Relases and Analysis

Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference

InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates

InspireMD Reports Third Quarter 2025 Financial Results

Earnings Scheduled For November 4, 2025

InspireMD Reports Second Quarter 2025 Financial Results

Earnings Scheduled For August 5, 2025

InspireMD Reports First Quarter 2025 Financial Results

Hologic (HOLX) Q4 Earnings and Revenues Beat Estimates

InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

InspireMD Announces the Appointment of Dan Dearen to its Board of Directors

InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference

RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors

InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors

InspireMD Announces Combined Financings of $58 Million

InspireMD to Announce Second Quarter 2025 Financial Results

InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke

InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke

InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer

InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic

InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates

Globus Medical (GMED) Lags Q1 Earnings and Revenue Estimates

IQVIA Holdings (IQV) Surpasses Q1 Earnings and Revenue Estimates

InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference

InspireMD to Announce First Quarter 2025 Financial Results

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference